Skin Findings in COVID-19 Patients
The skin findings in COVID-19 patients include a morbilliform rash, urticaria, vesicular eruptions, acral lesions (COVID toes), livedoid eruptions, and other nonspecific skin findings.
Skin findings of COVID-19 disease are similar to the cutaneous findings in other viral infections. Some of the skin findings are more commonly associated with COVID-19 infection than with other viruses sugg …
The skin findings in COVID-19 patients include a morbilliform rash, urticaria, vesicular eruptions, acral lesions (COVID toes), livedoid eruptions, and other nonspecific skin findings.
Skin findings of COVID-19 disease are similar to the cutaneous findings in other viral infections. Some of the skin findings are more commonly associated with COVID-19 infection than with other viruses sugg … 
As recent dermatology residency graduates like myself are well aware, the landscape is set – we will be taking our boards in October. Admittedly, when the ABD (American Board of Dermatology) inquired about when residents would like to take the exam, I responded – “July, please”. But as an entity that must look out for the interests of everyone while navigating the challenges of this pand … 
Mutations in which gene would likely be found in the neoplastic cells of this lesion?
A. PATCH
B. p53
C. Fumarate hydratase
D. CREBBP
E. p63
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
“2, 4, 6, 8… Who do we appreciate?” Dr. Julie C Harper from the Dermatology and Skin Care Center of Birmingham for giving us a rock-solid breakdown of hormonal therapies for acne. Although she didn’t lead us in cheers, she did teach us the “3, 6, 9, 12” of risk for venous thromboembolism in women of childbearing age. Read on to find out more!
Before we get into the “nitty-gritty,� … 
INTRODUCTION
Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic … 